1 recruiting, 1 unknown. 1 Early Phase 1, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Hemosiderosis, Pulmonary: new trials by email Literature Review of Hemosiderosis, Pulmonary trials Research Report on Hemosiderosis, Pulmonary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children Leflunomide, Steroid Drug - Idiopathic Pulmonary Hemosiderosis, Leflunomide | Phase 1 / Phase 2 | Recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 34 | 2023-06-01 | 2023-07-10 |
| Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis - Idiopathic Pulmonary Hemosiderosis | Early Phase 1 | Unknown | Sun Yat-sen University | 100 | 2017-01-01 | 2016-12-07 |
Hemosiderosis (2) · Iron Metabolism Disorders (2) · Iron Overload (2) · Lung Diseases (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Respiratory Tract Diseases (2)
Leflunomide (1)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · Sun Yat-sen University (1)
China (1)
PMID 15615854, PMID 15891110, PMID 19721001, PMID 21128750, PMID 21585237, PMID 23154940